Table 2.
Response | Number of responses | Prop. of responses (%) | Lead contact | Voltage | Frequency | Diagnosis | Patient |
---|---|---|---|---|---|---|---|
Numbness | 146 | 66.7 | 0.197 | 0.015* | 0.702 | 0.848 | <0.0001*** |
Changes in heart rate | 79 | 36.1 | 0.635 | 0.071 | <0.0001*** | <0.0001*** | <0.0001*** |
Pain | 37a | 16.9 | 0.573 | 0.425 | 0.454 | <0.0001*** | <0.0001*** |
Dizziness | 35 | 16 | 0.002** | 0.001** | 0.003** | 0.447 | 0.001** |
Eye closure | 24b | 11 | 0.595 | 0.335 | 0.157 | 0.058 | <0.0001*** |
Giddiness | 18 | 8.2 | 0.036* | <0.0001*** | <0.0001*** | 0.001** | <0.0001*** |
Involuntary movements | 18c | 8.2 | 0.008** | 0.534 | 0.553 | 0.001** | <0.0001*** |
Responses that occurred in <5% of the trials or in only one patient were omitted. Prop, proportion.
p < 0.05;
p < 0.01;
p < 0.001.
The total number of trials was 219.
36 reported in a patient with schizophrenia;
15 reported in another patient with schizophrenia;
12 reported in a patient with bipolar disorder.